Figure 3.
Increase over time in the proportion of cases assessed as “marked or moderate” for global improvement, overall improvement of subjective symptoms during non-menstruation, and overall improvement of objective findings.58
Note: Reprinted from Momoeda et al63 with permission from John Wiley & Sons.